Semaglutide, a GLP-1 receptor agonist found in Ozempic, helps control blood sugar by promoting the synthesis of insulin, decreasing the livers release of glucose, and delaying the intestinal absorption of sugar
Over three years, this translated to roughly six to seven fewer new diagnoses per 1,000 GLP-1 users
Additionally, by supporting metabolic health and weight management, GLP-1s may help reduce the severity of perimenopausal symptoms related to hormonal imbalances, such as fatigue and brain fog
This matters more in older adults, in anyone whose function depends on strength, and in anyone with low muscle reserve to start with
Semaglutide Injection Site Rash While semaglutide is generally well-tolerated, a rash at the injection site is a rare but possible side effect
Antagonist: Blocks a receptor